PDB Short entry for 1O1M HEADER OXYGEN STORAGE/TRANSPORT 17-NOV-02 1O1M TITLE DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29F,H58Q B,D:V1M,V67W) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DEOXYHEMOGLOBIN ALPHA CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HEMOGLOBIN BETA CHAIN; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: DEOXYHEMOGLOBIN BETA CHAIN; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: RED BLOOD CELL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 CELL: RED BLOOD CELL; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HEME, OXYGEN DELIVERY VEHICLE, BLOOD SUBSTITUTE, OXYGEN STORAGE- KEYWDS 2 TRANSPORT COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.A.BRUCKER REVDAT 7 16-AUG-23 1O1M 1 REMARK REVDAT 6 27-OCT-21 1O1M 1 REMARK SEQADV REVDAT 5 24-JUL-19 1O1M 1 REMARK REVDAT 4 23-AUG-17 1O1M 1 SOURCE REMARK REVDAT 3 24-FEB-09 1O1M 1 VERSN REVDAT 2 28-FEB-06 1O1M 1 JRNL REMARK REVDAT 1 18-DEC-02 1O1M 0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.A.BRUCKER REMARK 1 TITL GENETICALLY CROSSLINKED HEMOGLOBIN: A STRUCTURAL STUDY REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 56 812 2000 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444900006557 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.H.DOHERTY,M.P.DOYLE,S.R.CURRY,R.J.VALI,T.J.FATTOR, REMARK 1 AUTH 2 J.S.OLSON,D.D.LEMON REMARK 1 TITL RATE OF REACTION WITH NITRIC OXIDE DETERMINES THE REMARK 1 TITL 2 HYPERTENSIVE EFFECT OF CELL-FREE HEMOGLOBIN REMARK 1 REF NAT.BIOTECHNOL. V. 16 672 1998 REMARK 1 REFN ISSN 1087-0156 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.LOOKER,D.ABBOT-BROWN,P.COZART,S.DURFEE,S.HOFFMAN, REMARK 1 AUTH 2 A.J.MATHEWS,J.MILLER-ROEHRICH,S.SHOEMAKER,S.TRIMBLE,G.FERMI, REMARK 1 AUTH 3 N.H.KOMIYAMA,K.NAGAI,G.L.STETLER REMARK 1 TITL A HUMAN RECOMBINANT HEMOGLOBIN DESIGNED FOR USE AS A BLOOD REMARK 1 TITL 2 SUBSTITUTE REMARK 1 REF NATURE V. 356 258 1992 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/356258A0 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.0 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.200 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.198 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.107 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2210 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 41057 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.176 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.174 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.107 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1845 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 36126 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4399 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 339 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4895.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 2 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 19681 REMARK 3 NUMBER OF RESTRAINTS : 23153 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.015 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.005 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.037 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.009 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL. 91(1973) 201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1O1M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1000001689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-98 REMARK 200 TEMPERATURE (KELVIN) : 295.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE, XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43765 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 2.510 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.27700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.010 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1C7C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.82100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -108.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 142 REMARK 465 GLY A 143 REMARK 465 GLY A 144 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 VAL A 145 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 92 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 3 162.04 -46.58 REMARK 500 ASP A 75 44.50 -158.33 REMARK 500 ASP A 219 41.97 -147.70 REMARK 500 HIS B 2 104.90 59.39 REMARK 500 ASN B 80 56.10 -151.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 286 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 HEM A 286 NA 101.5 REMARK 620 3 HEM A 286 NB 101.3 87.3 REMARK 620 4 HEM A 286 NC 102.0 156.5 87.7 REMARK 620 5 HEM A 286 ND 101.9 87.6 156.7 88.0 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 287 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 231 NE2 REMARK 620 2 HEM A 287 NA 100.6 REMARK 620 3 HEM A 287 NB 100.2 87.8 REMARK 620 4 HEM A 287 NC 100.7 158.8 87.9 REMARK 620 5 HEM A 287 ND 100.8 88.4 158.9 88.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 147 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 147 NA 99.3 REMARK 620 3 HEM B 147 NB 99.7 88.1 REMARK 620 4 HEM B 147 NC 100.0 160.8 88.9 REMARK 620 5 HEM B 147 ND 99.6 88.0 160.7 88.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 147 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 147 NA 98.7 REMARK 620 3 HEM D 147 NB 99.1 88.2 REMARK 620 4 HEM D 147 NC 99.2 162.2 88.8 REMARK 620 5 HEM D 147 ND 99.2 88.5 161.7 89.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 147 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O1I RELATED DB: PDB REMARK 900 CYANOMET HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) REMARK 900 RELATED ID: 1O1J RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) REMARK 900 RELATED ID: 1O1K RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A,C:V1M; B,D:V1M,V67W) REMARK 900 RELATED ID: 1O1L RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29W,H58Q; B,D:V1M) REMARK 900 RELATED ID: 1O1N RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29W; B,D:V1M) REMARK 900 RELATED ID: 1O1O RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A,C:V1M,V67L; B,D:V1M, V67L) REMARK 900 RELATED ID: 1O1P RELATED DB: PDB REMARK 900 DEOXY HEMOGLOBIN (A-GLY-C:V1M; B,D: V1M, C93A, N108K) REMARK 999 REMARK 999 SEQUENCE REMARK 999 HUMAN HEMOGLOBIN HAS TWO ALPHA CHAINS WHICH ARE CALLED REMARK 999 CHAINS A AND C IN OTHER PDB FILES. IN THIS ENTRY THE REMARK 999 C-TERMINUS OF THE ALPHA-1 CHAIN AND THE N-TERMINUS OF THE REMARK 999 ALPHA-2 CHAIN ARE GENETICALLY LINKED BY THREE GLYCINE REMARK 999 RESIDUES TO FORM ONE COVALENTLY LINKED POLYPEPTIDE CHAIN. REMARK 999 THESE THREE RESIDUES ARE HIGHLY DISORDERED, I.E. NOT REMARK 999 DEFINED IN ELECTRON DENSITY. ALSO, THE INITIAL RESIDUE REMARK 999 OF THE ALPHA-2 CHAIN, JUST AFTER THE GLYCINE LINKER, IS REMARK 999 THE NATIVE VALINE, NOT A METHIONINE. THEREFORE, THE THREE REMARK 999 GLYCINE LINKER IS NOT INCLUDED IN THESE COORDINATES, AND REMARK 999 THE INITIAL RESIDUE OF THE ALPHA CHAIN(S) IS MODELED AS AN REMARK 999 ALANINE. DBREF 1O1M A 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1O1M A 145 285 UNP P69905 HBA_HUMAN 1 141 DBREF 1O1M B 1 146 UNP P68871 HBB_HUMAN 1 146 DBREF 1O1M D 1 146 UNP P68871 HBB_HUMAN 1 146 SEQADV 1O1M MET A 1 UNP P69905 VAL 1 ENGINEERED MUTATION SEQADV 1O1M PHE A 29 UNP P69905 LEU 29 ENGINEERED MUTATION SEQADV 1O1M GLN A 58 UNP P69905 HIS 58 ENGINEERED MUTATION SEQADV 1O1M GLY A 142 UNP P69905 LINKER SEQADV 1O1M GLY A 143 UNP P69905 LINKER SEQADV 1O1M GLY A 144 UNP P69905 LINKER SEQADV 1O1M PHE A 173 UNP P69905 LEU 29 ENGINEERED MUTATION SEQADV 1O1M GLN A 202 UNP P69905 HIS 58 ENGINEERED MUTATION SEQADV 1O1M MET B 1 UNP P68871 VAL 1 ENGINEERED MUTATION SEQADV 1O1M TRP B 67 UNP P68871 VAL 67 ENGINEERED MUTATION SEQADV 1O1M MET D 1 UNP P68871 VAL 1 ENGINEERED MUTATION SEQADV 1O1M TRP D 67 UNP P68871 VAL 67 ENGINEERED MUTATION SEQRES 1 A 285 MET LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 285 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 285 GLU ALA PHE GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 285 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 285 ALA GLN VAL LYS GLY GLN GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 285 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 285 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 285 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 285 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 285 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 285 SER VAL SER THR VAL LEU THR SER LYS TYR ARG GLY GLY SEQRES 12 A 285 GLY VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA SEQRES 13 A 285 ALA TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY SEQRES 14 A 285 ALA GLU ALA PHE GLU ARG MET PHE LEU SER PHE PRO THR SEQRES 15 A 285 THR LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SEQRES 16 A 285 SER ALA GLN VAL LYS GLY GLN GLY LYS LYS VAL ALA ASP SEQRES 17 A 285 ALA LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO SEQRES 18 A 285 ASN ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS SEQRES 19 A 285 LEU ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS SEQRES 20 A 285 CYS LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU SEQRES 21 A 285 PHE THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU SEQRES 22 A 285 ALA SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 MET HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS TRP LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 D 146 MET HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS TRP LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS HET HEM A 286 43 HET HEM A 287 43 HET HEM B 147 43 HET HEM D 147 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 4 HEM 4(C34 H32 FE N4 O4) FORMUL 8 HOH *339(H2 O) HELIX 1 1 SER A 3 GLY A 18 1 16 HELIX 2 2 HIS A 20 PHE A 36 1 17 HELIX 3 3 PRO A 37 PHE A 43 5 7 HELIX 4 4 SER A 52 HIS A 72 1 21 HELIX 5 5 ASP A 75 LEU A 80 1 6 HELIX 6 6 LEU A 80 LYS A 90 1 11 HELIX 7 7 PRO A 95 LEU A 113 1 19 HELIX 8 8 THR A 118 THR A 137 1 20 HELIX 9 9 SER A 147 GLY A 162 1 16 HELIX 10 10 HIS A 164 PHE A 180 1 17 HELIX 11 11 PRO A 181 PHE A 187 5 7 HELIX 12 12 SER A 196 HIS A 216 1 21 HELIX 13 13 ASP A 219 LEU A 224 1 6 HELIX 14 14 LEU A 224 LYS A 234 1 11 HELIX 15 15 PRO A 239 LEU A 257 1 19 HELIX 16 16 THR A 262 SER A 282 1 21 HELIX 17 17 THR B 4 GLY B 16 1 13 HELIX 18 18 ASN B 19 TYR B 35 1 17 HELIX 19 19 PRO B 36 GLY B 46 5 11 HELIX 20 20 THR B 50 GLY B 56 1 7 HELIX 21 21 ASN B 57 LEU B 75 1 19 HELIX 22 22 ALA B 76 LEU B 78 5 3 HELIX 23 23 ASN B 80 LYS B 95 1 16 HELIX 24 24 PRO B 100 GLY B 119 1 20 HELIX 25 25 LYS B 120 PHE B 122 5 3 HELIX 26 26 THR B 123 HIS B 143 1 21 HELIX 27 27 THR D 4 GLY D 16 1 13 HELIX 28 28 ASN D 19 TYR D 35 1 17 HELIX 29 29 PRO D 36 GLY D 46 5 11 HELIX 30 30 THR D 50 GLY D 56 1 7 HELIX 31 31 ASN D 57 LEU D 75 1 19 HELIX 32 32 ASN D 80 LYS D 95 1 16 HELIX 33 33 PRO D 100 GLY D 119 1 20 HELIX 34 34 LYS D 120 PHE D 122 5 3 HELIX 35 35 THR D 123 HIS D 143 1 21 LINK NE2 HIS A 87 FE HEM A 286 1555 1555 2.17 LINK NE2 HIS A 231 FE HEM A 287 1555 1555 2.18 LINK NE2 HIS B 92 FE HEM B 147 1555 1555 2.20 LINK NE2 HIS D 92 FE HEM D 147 1555 1555 2.16 SITE 1 AC1 15 TYR A 42 PHE A 43 HIS A 45 GLN A 58 SITE 2 AC1 15 LYS A 61 LEU A 83 LEU A 86 HIS A 87 SITE 3 AC1 15 LEU A 91 VAL A 93 ASN A 97 PHE A 98 SITE 4 AC1 15 LEU A 136 HOH A1045 HOH A1254 SITE 1 AC2 14 TYR A 186 PHE A 187 HIS A 189 GLN A 202 SITE 2 AC2 14 LYS A 205 LEU A 227 LEU A 230 HIS A 231 SITE 3 AC2 14 LEU A 235 VAL A 237 PHE A 242 LEU A 245 SITE 4 AC2 14 LEU A 280 HOH A1269 SITE 1 AC3 11 ALA A 53 PHE B 41 HIS B 63 LYS B 66 SITE 2 AC3 11 LEU B 91 HIS B 92 ASN B 102 VAL B 137 SITE 3 AC3 11 LEU B 141 HOH B1090 HOH B1107 SITE 1 AC4 11 PHE D 41 HIS D 63 TRP D 67 HIS D 92 SITE 2 AC4 11 LEU D 96 ASN D 102 LEU D 141 HOH D1002 SITE 3 AC4 11 HOH D1213 HOH D1239 HOH D1331 CRYST1 63.481 83.642 53.516 90.00 98.99 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015753 0.000000 0.002492 0.00000 SCALE2 0.000000 0.011956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018918 0.00000